Explore the Possibilities Our proprietary BIOACTIV™ combinatorial blocatalysis technology Integrates enzymatic, microbial and selected chemical transformations to generate highly focused libraries of hundreds or thousands of compounds based on a single lead candidate. Often with amazing chemo-, reglo-, and stereo- selectivity. Functlonallzed derivatives. Metabolites. Small molecule organlcs. Complex natural products. All delivered
to our customers as purified single compounds ready for high-throughput screening. Just think rapid access to a diverse array of high-quality test compounds not readily accessible by chemical methods alone. Speed up the derlvatlzatlon process. Broaden patent coverage. Evaluate novel transformations. Evaluate all of your hits, not just a selected few. The possibilities are endless. But with BIOACTIV™, the discovery and optimization of leads doesn't have to be.
EnzyMed A Division of Albany Molecular Research, Inc.
Alfrwiy M9tawtar
CIRCLE 2 ON READER SERVICE CARD
EnzyMed 2501 Crosspark Road, Iowa City, IA 52242 voice: 319-626-5400 • Fax: 319-626-5410 custservOenzymed.com • www.enzymed.com
